D SEED THERAPEUTICS
Live / Applied — Non-final action mailed (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 27 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99361665
- Mark type
- Design + words
- Filed
- 27 Aug 2025
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 042 — Scientific and technological services: drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell
Owner
- SEED Therapeutics US, Inc., King of Prussia, PA, US
Prosecution history
- 21 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — NON-FINAL ACTION WRITTEN
- 20 Jan 2026 — ASSIGNED TO EXAMINER
- 16 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 16 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Aug 2025 — NEW APPLICATION ENTERED